NYSE:BTX

Brooklyn Immunotherapeutics Stock Forecast

etoro logo Buy BTX
*Your capital is at risk
$6.48
-0.150 (-2.26%)
At Close: Nov 17, 2025
AI Analysis AI Analysis of BTX
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Brooklyn Immunotherapeutics Inc stock price down 2.26% on Monday
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Nov 12, 2025 Loss -6.36%

The Brooklyn Immunotherapeutics Inc stock price fell by -2.26% on the last day (Monday, 17th Nov 2025) from $6.63 to $6.48. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 3.74% from a day low at $6.43 to a day high of $6.67. The price has fallen in 7 of the last 10 days and is down by -7.16% for this period. Volume has increased on the last day by 162 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $6.76 million.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $6.42 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -4.51% during the next 3 months and, with a 90% probability hold a price between $6.13 and $6.79 at the end of this 3-month period.

BTX Signals & Forecast

There are few to no technical positive signals at the moment. The Brooklyn Immunotherapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $6.83 and $6.81. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, November 10, 2025, and so far it has fallen -9.24%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Brooklyn Immunotherapeutics Inc stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.240 between high and low, or 3.74%. For the last week, the stock has had daily average volatility of 3.37%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BTX) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Brooklyn Immunotherapeutics Inc to open at $6.52, and during the day (based on 14 day Average True Range), to move between $6.40 and $6.56, which gives a possible trading interval of +/-$0.156 (+/-2.43%) up or down from last closing price. If Brooklyn Immunotherapeutics Inc takes out the full calculated possible swing range there will be an estimated 2.43% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $6.91, some $0.430 (6.64%) from the current price of $6.48, our system finds the risk reward not very attractive.

Is Brooklyn Immunotherapeutics Inc stock A Buy?

Brooklyn Immunotherapeutics Inc holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.467 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $6.52 ( 0.669%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

BTX Performance

Trading levels for BTX

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 6.76 4.37%
R2 6.67 2.96%
R1 6.62 2.08%
Price 6.48
S1 6.43 -0.746%
S2 6.38 -1.62%
S3 6.28 -3.03%

Accumulated Volume Support & Resistance Levels

Level Price
R3 6.98 7.72%
R2 6.93 6.94%
R1 6.91 6.64%
Price 6.48
S1 0 -
S2 0 -
S3 0 -

BTX Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Nov 14, 2025 Nov 14, 2025 Nov 28, 2025 $0.0525 0.749%
2 Oct 15, 2025 Oct 15, 2025 Oct 31, 2025 $0.0525 0.760%
3 Sep 15, 2025 Sep 15, 2025 Sep 30, 2025 $0.0784 1.12%
4 Aug 15, 2025 Aug 15, 2025 Aug 29, 2025 $0.0788 1.08%
5 Jul 17, 2025 Jul 17, 2025 Jul 31, 2025 $0.0797 1.10%

FAQ

What is the symbol for Brooklyn Immunotherapeutics Inc Stock and on which exchange is it traded?
The symbol for Brooklyn Immunotherapeutics Inc is BTX and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Brooklyn Immunotherapeutics Inc Stock?
Brooklyn Immunotherapeutics Inc holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Brooklyn Immunotherapeutics Inc Stock?
Brooklyn Immunotherapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Brooklyn Immunotherapeutics Inc Stock.

What's the current price of Brooklyn Immunotherapeutics Inc Stock?
As of the end of day on the Nov 17, 2025, the price of an Brooklyn Immunotherapeutics Inc (BTX) share was $6.48.

What is the 52-week high and low for Brooklyn Immunotherapeutics Inc Stock?
The 52-week high for Brooklyn Immunotherapeutics Inc Stock is $8.31 and the 52-week low is $5.10.

What is the market capitalization of Brooklyn Immunotherapeutics Inc Stock?
As of the Nov 17, 2025, the market capitalization of Brooklyn Immunotherapeutics Inc is 756.283M.
Click to get the best stock tips daily for free!
ABOUT BROOKLYN IMMUNOTHERAPEUTICS INC
Brooklyn Immunotherapeutics
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics,...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE